OKLAHOMA CITY, April 04, 2018 -- Federman & Sherwood announces that on April 3, 2018, a class action lawsuit was filed in the United States District Court for the Southern District of New York against Longfin Corp. (NASDAQ:LFIN). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is December 15, 2017 through April 2, 2018.
Plaintiff seeks to recover damages on behalf of all Longfin Corp. shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above. You may move the Court no later than Monday, June 4, 2018 to serve as a lead plaintiff for the entire Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.
If you wish to discuss this action, obtain further information and participate in this or any other securities litigation, or should you have any questions or concerns regarding this notice or preservation of your rights, please contact:
Robin Hester
FEDERMAN & SHERWOOD
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
Email to: [email protected]
Or, visit the firm’s website at www.federmanlaw.com


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Amazon Explores AI Content Marketplace With Media Publishers
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Anta Sports Expands Global Footprint With Strategic Puma Stake
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



